Koers Coloplast A/S Other OTC
Aandelen
CLPBY
US19624Y2000
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 27,05 mld. 3,94 mld. 3,62 mld. | Omzet 2025 * | 29,39 mld. 4,28 mld. 3,94 mld. | Marktkapitalisatie | 189 mld. 27,57 mld. 25,36 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 5,25 mld. 764 mln. 702 mln. | Nettowinst (verlies) 2025 * | 6,13 mld. 892 mln. 821 mln. | EV/omzet 2024 * | 7,72 x |
Nettoschuld 2024 * | 19,4 mld. 2,82 mld. 2,6 mld. | Nettoschuld 2025 * | 17,9 mld. 2,61 mld. 2,4 mld. | EV/omzet 2025 * | 7,05 x |
K/w-verhouding 2024 * |
36,2
x | K/w-verhouding 2025 * |
30,9
x | Werknemers | - |
Dividendrendement 2024 * |
2,41% | Dividendrendement 2025 * |
2,62% | Vrij verhandelbaar | 58,44% |
Recentste transcriptie over Coloplast A/S
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-01-08 | |
Director of Finance/CFO | 52 | 01-01-06 | |
Chairman | 65 | 01-01-88 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 76 | 01-10-68 | |
Carsten Hellmann
BRD | Director/Board Member | 60 | 01-12-17 |
Chairman | 65 | 01-01-88 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-35,22% | 3,03 mld. | |
-21,21% | 2,39 mld. | |
+5,74% | 2,18 mld. | |
-11,31% | 1,9 mld. | |
+21,11% | 1,88 mld. | |
+23,77% | 1,3 mld. | |
+13,02% | 1,23 mld. | |
-4,47% | 1,23 mld. | |
+21,08% | 1,22 mld. |